Association of Suicidality and Depression with 5α-Reductase Inhibitors

    August 2017 in “ ˜The œJournal of urology/˜The œjournal of urology ”
    Steven A. Kaplan
    TLDR 5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.
    This study analyzed the mental health consequences of long-term use of 5α-reductase inhibitors in 93,197 men aged 66 or older in Ontario, Canada, from 2003 to 2013. It found no association between these inhibitors and an increase in suicide rates. However, there was a significant increase in the risks of self-harm and depression, particularly during the first 18 months of treatment. The study highlighted the need for healthcare providers to be more aware of the potential adverse effects of chronic medications and to counsel patients accordingly. The findings also raised questions about whether the observed mental health issues were due to the medication itself or the underlying condition being treated.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 83 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 month ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  41 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 10 months ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 1 year ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

    Similar Research

    6 / 1000+ results